findmyKOL
Clinical trialNCT01573702CompletedPhase 2Interventional

Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)

SponsorUNC Lineberger Comprehensive Cancer CenterEnrollment32Non Small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California at San Francisco

    San Francisco, California, United States

  • University of Colorado Cancer Center

    Aurora, Colorado, United States

  • Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolina, United States

  • East Carolina University

    Greenville, North Carolina, United States

  • Sto Taussig Cancer Center; Cleveland Clinic

    Cleveland, Ohio, United States

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States

  • Swedish Cancer Institute

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
11 Dec 2012
Primary completion
15 Mar 2019
Completion
15 Mar 2019
Last update posted
12 Jan 2021
Registered enrollment
32
Registry id
NCT01573702

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.